We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Sign up to read this article for FREE!

After signing up, you'll start to receive regular news updates from us.

A New Dimension in Drug Discovery with the Asia Flow Chemistry System

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

The Discovery Chemistry Department at Gedeon Richter in Budapest, Hungary, has invested in an Asia flow chemistry system from Syrris to aid researchers involved in the design and synthesis of original CNS drugs.

Research scientist Dr György Túrós explained: “In discovery chemistry research, we need to perform a lot of very interesting and complex chemical syntheses and, until now, have relied on classical batch chemistry methods.”

“We purchased an Asia flow chemistry reactor in June, and are now reaping the benefits of using flow chemistry techniques. The system has extended the range of chemistries available to us, allowing us to work at much higher pressures and temperatures - sometimes above a solvent’s boiling point - to create completely new heterocyclic scaffolds. We can combine the Asia modules in a variety of different ways to meet changing needs, and will also be able to add additional modules at a later date if required. This was an important consideration, and one of the main reasons for choosing Asia. Syrris has been very supportive, giving us some valuable ideas and flow chemistry tips during our training, and we can now do chemistry which was absolutely impossible before. In my opinion, Syrris is as innovative in the synthetic chemistry arena as Google or Apple in the informatics field.”